Probiotic Bacteria in Dietetic Products for Infants: A Commentary by the ESPGHAN Committee on Nutrition

Journal of Pediatric Gastroenterology and Nutrition

Volumn 38, Issue 4, 2004, Pages 365-374

  Agostoni, Carlo ^a   Axelsson, Irene ^b   Braegger, Christian ^b   Goulet, Olivier ^c   Koletzko, Berthold ^c   Michaelsen, Kim F ^d   Rigo, Jacques ^d   Shamir, Raanan ^d   Szajewska, Hania ^e   Turck, Dominique ^e   Weaver, Lawrence T ^e  

^a UNIVERSITY OF MILAN   (Italy)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; ARTIFICIAL MILK; BABY FOOD; HUMAN; INFANT; INFANT NUTRITION; META ANALYSIS; MICROBIOLOGY; NEWBORN; PREMATURITY; SAFETY;

HUMANS; INFANT; INFANT FOOD; INFANT FORMULA; INFANT NUTRITION PHYSIOLOGY; INFANT, NEWBORN; INFANT, PREMATURE; META-ANALYSIS; PROBIOTICS; SAFETY;

EID: 4344613543     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/00005176-200404000-00001     Document Type: Article

References (84)

1. Satokari RM, Vaughan EE, Favier CF, et al. Diversity of Bifidobacterium and Lactobacillus spp. in breast-fed and formula-fed infants as assessed by 16S rDNA sequence differences. Microb Ecol Health Dis 2002;14:97-105.
2. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000;30:61-7.
3. Rubaltelli FF, Biadaioli R, Pecile P, et al. Intestinal flora in breast-and bottle-fed infants. J Perinat Med 1998;26:186-91.
4. Heine W, Mohr C, Wutzke KD. Host-microflora correlations in infant nutrition. Prog Food Nutr Sci 1992;16:181-97.
5. Ouwehand A, Isolauri E, Salminen S. The role of the intestinal microflora for the development of the immune system in early childhood. Eur J Nutr 2002;41(Suppl 1):132-7.
6. Kunz C, Rodriguez-Palmero M, Koletzko B, et al. Nutritional and biochemical properties of human milk. Part I: General aspects, proteins, and carbohydrates. Clin Perinatol 1999;26:307-33.
7. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-9.
8. Aggett P, Agostoni C, Axelsson I, et al. Non-digestible carbohydrates in the diets of infants and young children. A commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2003;36:329-37.
9. Howie PW. Protective effect of breastfeeding against infection in the first and second six months of life. Adv Exp Med Biol 2002;503:141-7.
10. Howie PW, Forsyth JS, Ogston SA, Protective effect of breast feeding against infection. Br Med J 1990;300:11-16.
11. Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
12. Kelleher SL, Casas I, Carbajal N, et al. Supplementation of infant formula with the probiotic Lactobacillus reuteri and zinc: impact on enteric infection and nutrition in infant rhesus monkeys. J Pediatr Gastroenterol Nutr 2002;35:162-8.
13. Sudo N, Sawamura S, Tanaka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739-45.
14. Lilly DM, Stillwell RH. Probiotics: growth promoting factors produced by microorganisms. Science 1965;147:747-8.
15. Diplock AT, Aggett PJ, Ashwell M, et al. Scientific concepts of functional foods in Europe: consensus document. Br J Nutr 1999;81(Suppl 1):S1-27.
16. Bernardeau M, Vernoux JP, Gueguen M. Safety and efficacy of probiotic lactobacilli in promoting growth in post-weaning Swiss mice. Int J Food Microbiol 2002;77:19-27.
17. Rachmilewitz D, Karmeli F, Takabayashi K, et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002;122:1428-41.
18. Madsen K, Jijon H, Yeung H, et al. DNA from probiotic bacteria exerts anti-inflammatory actions on epithelial cells by inhibition of NFκB [abstract]. Gastroenterology 2002;122:A-64.
19. Salminen S, Ouwehand A, Benno Y, et al. Probiotics: how should they be defined?Trend Food Sci Technol 1999;10:107-10.
20. FAO/WHO (Food and Agriculture Organization/World Health Organisation). Joint FAO/WHO Working Group Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada:; 2002.
21. Blaut M, Collins MD, Welling GW, et al. Molecular biologic methods for studying the gut microbiota: the EU human gut flora project. Br J Nutr 2002;87(Suppl 2):203-11.
22. FAO/WHO (Food and Agriculture Organization/World Health Organisation). Joint FAO/WHO Working Group Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada: 2002.
23. AFSSA (Agence Française de Sécurité Sanitaire des Aliments). Alimentation Infantile et Modification de la Flore Intestinale (working document). 2003.
24. Scientific Committee on Food. European Commission. Health and Consumer Protection Directorate-General. Report of the Scientific Committee on Food on the Revision of Essential Requirements of Infant Formulas and Follow-up Formulas (adopted April 4, 2003). SCF/CS/NUT/IF/65 Final 18 May 2003;. Accessed January 30, 2004.
25. Saavedra J, Bauman NA, Oung I, et al. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 1994;344:1046-9.
26. Phuapradit P, Varavithya W, Vathanophas K, et al. Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula. J Med Assoc Thai 1999;82(Suppl 1):S43-8.
27. Langhendries JP, Detry J, Van Hees J, et al. Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J Pediatr Gastroenterol Nutr 1995;21:177-81.
28. Nopchinda S, Varavithya W, Phuapradit P, et al. Effect of Bifidobacterium Bb12 with or without Streptococcus thermophilus supplemented formula on nutritional status. J Med Assoc Thai 2002;85(Suppl 4):S1225-31.
29. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-85.
30. Isolauri E, Arvola T, Sutas Y, et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30:1604-10.
31. Jadad A, Moore R, Carroll D, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary?Control Clin Trials 1996;17:1-12.
32. Aggett PJ, Agostini C, Goulet O, et al. European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition. The nutritional and safety assessment of breast milk substitutes and other dietary products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2001;32:256-8.
33. Koletzko B, Ashwell M, Beck B, et al. Characterisation of infant food modifications in the European Union. Ann Nutr Metab 2002;46:231-42.
34. Van Niel C, Feudtner C, Garrison MM, et al. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002;109:678-84.
35. Szajewska H, Mrukowicz J. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo controlled trials. J Pediatr Gastroenterol Nut r 2001;33:S17-25.
36. Rosenfeldt V, Michaelson KF, Jakobsen M, et al. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatr Infect Dis J 2002;21:411-6.
37. Rosenfeldt V, Michaelsen KF, Jakobsen M, et al. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr Infect Dis J 2002;21:417-9.
38. D’Souza AL, Rajkumar C, Cooke J, et al. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002;324:1361-4.
39. Cremonini F, di Caro S, Nista EC, et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002;16:1461-7.
40. Tankanov RM, Ross MB, Ertel IJ, et al. Double blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhoea. DICP 1990;24:382-4.
41. Jirapinyo P, Thamonsiri N, Densupsoontorn N, et al. Prevention of antibiotic-associated diarrhea in infants by probiotics. J Med Assoc Thai 2002;85(Suppl 2):S739-42.
42. Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhoea in children. J Pediatr 1999;135:564-8.
43. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999;104:e64.
44. Thomas MR, Litin SC, Osmon DR, et al. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo controlled trial. Mayo Clinic Proc 2001;76:883-9.
45. Szajewska H, Kotowska M, Mrukowicz J, et al. Lactobacillus GG in prevention of diarrhea in hospitalised children. J Pediatr 2001;138:361-5.
46. Mastretta E, Longo P, Laccisaglia A, et al. Lactobacillus GG and breast feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 2002;35:527-31.
47. Oberhelman RA, Gilman R, Sheen P, et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 1999;134:15-20.
48. Hatakka K, Savilahti E, Ponka A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centers: double blind, randomised trial. Br Med J 2001;322:1-5.
49. Nase L, Hatakka K, Savilahti E, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res 2001;35:412-20.
50. Kalliomakki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001;357:1076-9.
51. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003;361:1869-71.
52. Roselfeldt V, Benfeldt E, Nielsen SD, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003;111:389-95.
53. Gupt P, Andrew H, Kirschner BS, et al. Is Lactobacillus GG helpful in children with Crohn’s disease? Results of a preliminary open-label study. J Pediatr Gastroenterol Nutr 2000;31:453-7.
54. LGG multicenter Study Group. A multicenter, placebo-controlled, double-blind study of Lactobacillus GG in addition to standard maintenance therapy in children with Crohn’s disease. North American Society of Pediatric Gastroenterology, Hepatology and Nutrition Meeting, October 24-27, 2002, San Antonio, Texas. J Pediatr Gastroenterol Nutr 2002;35:406.
55. Aylward GP, Pfeiffer SI, Wright A, et al. Outcome studies of LBW infants published in last decade: a meta-analysis. J Pediatr 1989;115:515-20.
56. Caplan MS, Jilling T. Neonatal necrotizing enterocolitis: possible role of probiotic supplementation. J Pediatr Gastroenterol Nutr 2000;30:S18-22.
57. Gronlund MM, Lehtonen OP, Kero P, et al. Lactobacillus GG supplementation does not reduce faecal colonization of Klebsiella oxytoca in preterm infants. Acta Paediatr 1997;86:440-1.
58. Millar MR, Bacon C, Smith SL, et al. Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child. 1993;69:483-7.
59. Agarwal R, Sharma N, Chaudhry R, et al. Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. J Pediatr Gastroenterol Nutr 2003;36:397-402.
60. Reuman PD, Duckworth DH, Smith KL, et al. Lack of effect of Lactobacillus on gastrointestinal bacterial colonization in premature infants. Pediatr Infect Dis 1986:5:663-8.
61. Kitajima H, Sumida Y, Tanaka R, et al. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 1997;76:F101-7.
62. Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999;3:197-202.
63. Dani C, Biadaioli R, Bertini G, et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002;82:103-8.
64. Naidu AS, Bidlack WR, Clemens RA. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr 1999;39:13-126.
65. Borritello SP, Hammes WP, Holzapfel W, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003;36:775-80.
66. Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr 2001;73(Suppl):465S-70S.
67. Salminen S, von Wright A, Morelli, et al. Demonstration of safety of probiotics-a review. Int J Food Microbiol 1998;44:93-106.
68. Piarroux R, Millon L, Bardonnet K, et al. Are live Saccharomyces yeasts harmful to patients?Lancet 1999;353:1851-2.
69. Rautio M, Jousimies-Somer H, Kauma H, et al. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999;28:1159-60.
70. Husni RN, Gordon SM, Washington JA, et al. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 1997;25:1048-55.
71. Thompson C, McCarter Y, Krause PJ, et al. Lactobacillus acidophilus sepsis in a neonate. J Perinatol 2001;21:258-60.
72. Bayer AS, Chow AW, Betts D, et al. Lactobacillemia: report of nine cases. Important clinical and therapeutic considerations. Am J Med 1978;64:808-13.
73. Broughton RA, Gruber WC, Haffar AA, et al. Neonatal meningitis due to Lactobacillus. Pediatr Infect Dis 1983;2:382-4.
74. Sharpe ME, Hill LR, Lapage SP. Pathogenic lactobacilli. J Med Microbiol 1973;6:281-6.
75. Kalima P, Masterton RG, Roddie PH, et al. Lactobacillus rhamnosus infection in a child following bone marrow transplant. J Infect 1996;32:165-7.
76. Brook I. Isolation of non-sporing anaerobic rods from infections in children. J Med Microbiol 1996;45:21-6.
77. Mackay AD, Taylor MB, Kibbler CC, et al. Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 1999;5:290-2.
78. Hennequin C, Kauffmann-Lacroix C, Jobert A, et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis 2000;19:16-20.
79. Spinosa MR, Wallet F, Courcol RJ, et al. The trouble in tracing opportunistic pathogens: cholangitis due to Bacillus in a French hospital caused by a strain related to an Italian probiotic?Microb Ecol Health Dis 2000;12:99-101.
80. Oggioni MR, Pozzi G, Balensin PE, et al. Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol 1998;36:325-6.
81. Richard V, Auwera P, Snoeck R, et al. Nosocomial bacteremia caused by Bacillus species. Eur J Clin Microbiol Infect Dis 1988;7:783-5.
82. Salminen MK, Tynkkynen S, Rautelin H, et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002;35:1155-60.
83. Marteau P. Safety aspects of probiotic products. Scand J Nutr 2001;45:22-24.
84. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001;292:1115-8.